Apr 9 |
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
|
Apr 9 |
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Apr 9 |
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
|
Apr 9 |
Dow Dips 150 Points; Laser Photonics Shares Spike Higher
|
Apr 9 |
Vincerx in selloff after early-stage data for cancer therapy
|
Apr 9 |
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
|
Apr 8 |
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Apr 1 |
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
Apr 1 |
Vincerx Pharma GAAP EPS of -$0.23 beats by $0.06
|
Mar 29 |
Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look
|